• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年人非酒精性脂肪性肝病的无声负担:全球疾病负担分析。

The silent burden of non-alcoholic fatty liver disease in the elderly: A global burden of disease analysis.

机构信息

Immunology Unit, Department of Microbiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.

Yong Loo Lin School of Medicine, National University of Singapore, Singapore.

出版信息

Aliment Pharmacol Ther. 2023 Nov;58(10):1062-1074. doi: 10.1111/apt.17714. Epub 2023 Sep 11.

DOI:10.1111/apt.17714
PMID:37694808
Abstract

BACKGROUND

Non-alcoholic fatty liver disease (NAFLD) represents a significant health threat worldwide. The growing trend towards an aging population, along with an alarming rise in obesity and diabetes, may have significant implications for the burden of NAFLD.

AIM

To assess the impact of NAFLD on the elderly.

METHODS

We utilised data from the Global Burden of Disease study between 2010 and 2019 to conduct a comprehensive analysis of the prevalence, mortality, and disability-adjusted life years (DALYs) associated with NAFLD in the elderly (65-89 years), stratified by region, nation, sociodemographic Index and sex.

RESULTS

Globally, there were an estimated 228 million cases, 87,230 deaths and 1.46 million DALYs attributed to NAFLD in the elderly. Geographically, the Western Pacific region had the highest burden of NAFLD in the elderly. From 2010 to 2019, there was an increasing prevalence rate in all areas, with the most pronounced change observed in the Western Pacific region (annual percentage change (APC) +0.95%, p < 0.001). Over the study period, there was a more rapid increase in NAFLD prevalence in men (APC +0.74%, p < 0.001) than in women (APC +0.63%, p < 0.001). In most regions, death and DALYs rates have declined, with the exception of the Americas, where there was a slight increase (APC +0.25%, p = 0.002 and 0.38%, p < 0.001, respectively).

CONCLUSION

Over the past decade, the burden of NAFLD in the elderly has been increasing, necessitating immediate and inclusive measures to tackle the rising burden.

摘要

背景

非酒精性脂肪性肝病(NAFLD)是全球范围内的一个重大健康威胁。人口老龄化趋势的增长,加上肥胖症和糖尿病发病率的惊人上升,可能对 NAFLD 的负担产生重大影响。

目的

评估 NAFLD 对老年人的影响。

方法

我们利用 2010 年至 2019 年全球疾病负担研究的数据,对老年人(65-89 岁)中与 NAFLD 相关的患病率、死亡率和残疾调整生命年(DALY)进行了全面分析,按地区、国家、社会人口指数和性别进行了分层。

结果

全球范围内,估计有 2.28 亿例、87230 例死亡和 146 万 DALY 归因于老年人的 NAFLD。从地理上看,西太平洋地区老年人的 NAFLD 负担最重。从 2010 年到 2019 年,所有地区的患病率都呈上升趋势,西太平洋地区的变化最为显著(年变化百分比(APC)+0.95%,p<0.001)。在研究期间,男性(APC+0.74%,p<0.001)的 NAFLD 患病率增长速度快于女性(APC+0.63%,p<0.001)。在大多数地区,死亡率和 DALY 率都有所下降,但美洲地区略有上升(APC+0.25%,p=0.002 和 0.38%,p<0.001)。

结论

在过去十年中,老年人的 NAFLD 负担一直在增加,需要立即采取全面措施来应对这一日益增加的负担。

相似文献

1
The silent burden of non-alcoholic fatty liver disease in the elderly: A global burden of disease analysis.老年人非酒精性脂肪性肝病的无声负担:全球疾病负担分析。
Aliment Pharmacol Ther. 2023 Nov;58(10):1062-1074. doi: 10.1111/apt.17714. Epub 2023 Sep 11.
2
Burden of non-alcoholic fatty liver disease in Asia, the Middle East and North Africa: Data from Global Burden of Disease 2009-2019.非酒精性脂肪性肝病在亚洲、中东和北非地区的负担:来自 2009-2019 年全球疾病负担的数据。
J Hepatol. 2021 Oct;75(4):795-809. doi: 10.1016/j.jhep.2021.05.022. Epub 2021 May 31.
3
The burden of non-alcoholic fatty liver disease among working-age people in the Western Pacific Region, 1990-2019: an age-period-cohort analysis of the Global Burden of Disease study.《1990-2019 年西太平洋地区工作年龄人群非酒精性脂肪性肝病负担:全球疾病负担研究的年龄-时期-队列分析》。
BMC Public Health. 2024 Jul 11;24(1):1852. doi: 10.1186/s12889-024-19047-y.
4
The Global, Regional, and National Burden and Trends of NAFLD in 204 Countries and Territories: An Analysis From Global Burden of Disease 2019.204 个国家和地区非酒精性脂肪性肝病的全球、区域和国家负担及趋势:基于 2019 年全球疾病负担研究的分析。
JMIR Public Health Surveill. 2022 Dec 12;8(12):e34809. doi: 10.2196/34809.
5
Burden of liver complications related to non-alcoholic fatty liver disease in China from 2005 to 2019: Observations from the Global Burden of Disease Study, 2019.2005年至2019年中国非酒精性脂肪性肝病相关肝脏并发症负担:基于2019年全球疾病负担研究的观察结果
Diabetes Obes Metab. 2023 Apr;25 Suppl 1:43-52. doi: 10.1111/dom.15010. Epub 2023 Mar 7.
6
The Surreptitious Burden of Nonalcoholic Fatty Liver Disease in the Elderly in the Asia-Pacific Region: An Insight from the Global Burden of Disease Study 2019.亚太地区老年人非酒精性脂肪性肝病的隐匿负担:来自《2019年全球疾病负担研究》的洞察
J Clin Med. 2023 Oct 11;12(20):6456. doi: 10.3390/jcm12206456.
7
Global Burden of Nonalcoholic Fatty Liver Disease, 1990 to 2019: Findings From the Global Burden of Disease Study 2019.全球非酒精性脂肪性肝病负担,1990 年至 2019 年:2019 年全球疾病负担研究结果。
J Clin Gastroenterol. 2023 Jul 1;57(6):631-639. doi: 10.1097/MCG.0000000000001739.
8
Changes in the Global Burden of Chronic Liver Diseases From 2012 to 2017: The Growing Impact of NAFLD.2012 年至 2017 年全球慢性肝病负担的变化:非酒精性脂肪性肝病的影响日益增加。
Hepatology. 2020 Nov;72(5):1605-1616. doi: 10.1002/hep.31173. Epub 2020 Oct 27.
9
Global burden of non-alcoholic fatty liver disease in 204 countries and territories from 1990 to 2019.1990年至2019年204个国家和地区非酒精性脂肪性肝病的全球负担。
Clin Res Hepatol Gastroenterol. 2023 Jan;47(1):102068. doi: 10.1016/j.clinre.2022.102068. Epub 2022 Dec 10.
10
Changing epidemiology of cirrhosis from 2010 to 2019: results from the Global Burden Disease study 2019.2010 年至 2019 年肝硬化流行病学变化:2019 年全球疾病负担研究结果。
Ann Med. 2023;55(2):2252326. doi: 10.1080/07853890.2023.2252326.

引用本文的文献

1
Liver cirrhosis in 2021: Global Burden of Disease study.2021年肝硬化:全球疾病负担研究
PLoS One. 2025 Jul 18;20(7):e0328493. doi: 10.1371/journal.pone.0328493. eCollection 2025.
2
Risk Factors for Non-alcoholic Fatty Liver Disease from the Perspective of Medical Professionals: A Systematic Review and Expert Opinion.从医学专业人员角度看非酒精性脂肪性肝病的危险因素:一项系统综述与专家意见
Middle East J Dig Dis. 2025 Jan;17(1):54-59. doi: 10.34172/mejdd.2025.408. Epub 2025 Jan 31.
3
Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment.
肝细胞癌:流行病学、监测、诊断与治疗的最新进展
Clin Mol Hepatol. 2025 Feb;31(Suppl):S228-S254. doi: 10.3350/cmh.2024.0824. Epub 2024 Dec 26.
4
Increased mortality from alcohol use disorder, alcohol-associated liver disease, and liver cancer from alcohol among older adults in the United States: 2000 to 2021.2000年至2021年美国老年人中酒精使用障碍、酒精相关肝病和酒精所致肝癌导致的死亡率上升。
Alcohol Clin Exp Res (Hoboken). 2025 Feb;49(2):368-378. doi: 10.1111/acer.15516. Epub 2024 Dec 19.
5
Global, Regional, and National Trends in Liver Disease-Related Mortality Across 112 Countries From 1990 to 2021, With Projections to 2050: Comprehensive Analysis of the WHO Mortality Database.1990年至2021年112个国家肝脏疾病相关死亡率的全球、区域和国家趋势及到2050年的预测:对世界卫生组织死亡率数据库的综合分析
J Korean Med Sci. 2024 Dec 2;39(46):e292. doi: 10.3346/jkms.2024.39.e292.
6
Burden landscape of hepatobiliary and pancreatic cancers in Chinese young adults: 30 years' overview and forecasted trends.中国年轻成年人肝胆胰癌的疾病负担情况:30年概述及预测趋势
World J Gastrointest Oncol. 2024 Oct 15;16(10):4177-4193. doi: 10.4251/wjgo.v16.i10.4177.
7
Long-term outcomes and risk modifiers of metabolic dysfunction-associated steatotic liver disease between lean and non-lean populations.瘦人群与非瘦人群中代谢功能障碍相关脂肪性肝病的长期结局及风险修饰因素
Clin Mol Hepatol. 2025 Jan;31(1):74-89. doi: 10.3350/cmh.2024.0631. Epub 2024 Oct 23.
8
Mortality outcomes in individuals with MASLD versus MASLD and increased alcohol intake.患有代谢功能障碍相关脂肪性肝病(MASLD)的个体与患有MASLD且酒精摄入量增加的个体的死亡率结果。
J Gastroenterol Hepatol. 2024 Nov;39(11):2456-2463. doi: 10.1111/jgh.16726. Epub 2024 Aug 22.
9
Changes in the epidemiological trends of primary liver cancer in the Asia-Pacific region.亚太地区原发性肝癌的流行病学趋势变化。
Sci Rep. 2024 Aug 22;14(1):19544. doi: 10.1038/s41598-024-70526-z.
10
Serum immunoglobulin A levels: Diagnostic utility in alcoholic liver disease and association with liver fibrosis in steatotic liver disease.血清免疫球蛋白A水平:在酒精性肝病中的诊断效用及与脂肪性肝病肝纤维化的关联
Biomed Rep. 2024 Aug 1;21(4):142. doi: 10.3892/br.2024.1830. eCollection 2024 Oct.